You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 7, February 20, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Pharmaceutical Representatives and Resident Physicians

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr McCormick and colleagues1 found that residents' attitudes and behavior were influenced by the amount of their exposure to pharmaceutical company representatives. As a resident in a program that has a long commitment to independence from pharmaceutical representatives, I support the authors' conclusions.

When patients ask me about the availability of complimentary samples at our practice, I am proud to tell them of our policy barring pharmaceutical representatives. We in the medical profession have primarily our integrity to offer patients; without our patients' trust how can we expect them to follow our advice for treatment or even to forgive us our human mistakes? When I explain to my patients that my recommendations to them are based on studies published with disclosure in journals and not on my gratitude for a "drug lunch," they rarely complain about our lack of free medication.

As I complete my residency and . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.